FIELD: medicine.
SUBSTANCE: invention can be used in practical healthcare to assess the anti-reflux effect of drinking mineral water. To identify the anti-reflux effect of drinking mineral water, the number of gastroesophageal refluxes is determined before and after taking 200 ml of the studied drinking mineral water at room temperature. A decrease in the number of gastroesophageal refluxes by 25% or more after taking mineral water indicates its antireflux effect on a given person, a decrease of less than 25%, an increase or lack of dynamics indicates the absence of an antireflux effect.
EFFECT: method provides an increase in the efficiency of assessing the antireflux effect of drinking mineral water.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
DIAGNOSTIC TECHNIQUE FOR VAPING-DEPENDENT DISORDERS OF OBTURATOR FUNCTION OF LOWER OESOPHAGEAL SPHINCTER | 2024 |
|
RU2821476C1 |
METHOD OF COMPLEX TREATMENT OF GASTROESOPHAGEAL DISEASE IN PATIENTS WITH OPISTHORCHOSIS | 2010 |
|
RU2420294C1 |
DIAGNOSTIC TECHNIQUE FOR GASTROESOPHAGEAL REFLUX DISEASE | 2012 |
|
RU2543346C2 |
METHOD FOR PREDICTING GASTROESOPHAGEAL REFLUX DISEASE | 2004 |
|
RU2257142C1 |
METHOD OF DIAGNOSTICS OF THE BARRETT ESOPHAGUS IN PATIENTS WITH COMPLICATIONS FROM GASTROESOPHAGEAL REFLUX DISEASE | 2017 |
|
RU2655807C1 |
METHOD FOR TREATING GASTROESOPHAGEAL REFLUX CASES | 2006 |
|
RU2318550C1 |
METHOD FOR DIAGNOSING HIGH GASTROESOPHAGEAL REFLUXES | 2017 |
|
RU2659955C1 |
METHOD FOR SURGICAL TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE IN PATIENTS AFTER LONGITUDINAL RESECTION OF THE STOMACH | 2022 |
|
RU2782301C1 |
METHOD FOR TREATING EROSIVE FORM OF GASTROESOPHAGEAL REFLUX DISEASE IN PATIENTS PUT ON CHEMOTHERAPY | 2017 |
|
RU2667651C1 |
METHOD OF REFLUX GASTROESOPHAGITIS MEDICAL TREATMENT | 2006 |
|
RU2325932C1 |
Authors
Dates
2023-08-08—Published
2022-12-03—Filed